BIMATOPROST Pharmacologic Class Indexing

Class set ID
340aafe4-b86c-4b93-a18b-a7afc4140b21
Version
4
Effective date
20191108
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.01% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.01%. BIMATOPROST ophthalmic solution 0.01%, for topical ophthalmic use Initial U.S. Approval: 2001First Nation Group, LLC | Mankind Pharma Limited202604081
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.01% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.01%. BIMATOPROST ophthalmic solution 0.01%, for topical ophthalmic use Initial U.S. Approval: 2001Lifestar Pharma LLC | Mankind Pharma Limited202603174
These highlights do not include all the information needed to use ZOLYMBUS™ safely and effectively. See full prescribing information for ZOLYMBUS™. ZOLYMBUS™ (bimatoprost ophthalmic gel) 0.01%, for topical ophthalmic use Initial U.S. Approval: 2001Thea Pharma Inc.202602255
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001NuCare Pharmaceuticals,Inc.202601095
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use. Initial U.S. Approval: 2001Alembic Pharmaceuticals Inc. | Gland Pharma Limited | Alembic Pharmaceuticals Limited (F3)2025121015
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001Alembic Pharmaceuticals Inc. | Gland Pharma Limited | Alembic Pharmaceuticals Limited (F3)2025120413
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001Apotex Corp.202509167
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.01% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.01% . BIMATOPROST ophthalmic solution 0.01%, for topical ophthalmic use Initial U.S. Approval: 2001Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited202505244
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.03%. BIMATOPROST ophthalmic solution 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001Somerset Therapeutics, LLC | Somerset Therapeutics Private Limited2025032211
These highlights do not include all the information needed to use DURYSTA safely and effectively. See full prescribing information for DURYSTA. DURYSTA ® ( bimatoprost intracameral implant), for intracameral administration Initial U.S. Approval: 2001Allergan, Inc.2024101615
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001Micro Labs Limited202409269
These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE ® (bimatoprost ophthalmic solution) 0.03% , for topical ophthalmic use Initial U.S. Approval: 2001Allergan, Inc.2024070125
These highlights do not include all the information needed to use LUMIGAN 0.01% safely and effectively. See full prescribing information for LUMIGAN 0.01%. LUMIGAN ® (bimatoprost ophthalmic solution) 0.01% , for topical ophthalmic use Initial U.S. Approval: 2001Allergan, Inc.2024060118
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION0N, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001NuCare Pharmaceuticals,Inc.202403251
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001Sandoz Inc2023083122
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3)202308251
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use. Initial U.S. Approval: 2001Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3)202307191
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001Aurobindo Pharma Limited | Eugia Pharma Specialities Limited202307172
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION0N, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001Fosun Pharma USA Inc.202206096
These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001Gland Pharma Limited202204126
Lumigan 03Allergan, Inc.201812079
These highlights do not include all the information needed to use LUMIGAN ® 0.01% and 0.03% (bimatoprost ophthalmic solution) safely and effectively. See full prescribing information for LUMIGAN ® . LUMIGAN ® 0.01% and 0.03% (bimatoprost ophthalmic solution) Initial U.S. Approval: 2001Physicians Total Care, Inc.201008312